News
  • 30 Cellvizio abstracts accepted at DDW 2012

    30 Cellvizio abstracts accepted at DDW 2012

    30 Cellvizio abstracts have been accepted at this year's Digestive Disease Week in San Diego, CA , May 19-22, 2012. Download the PDF

    14/05/2012

    more

  • Mauna Kea Donates $100,000 to ASGE's Training Center

    Mauna Kea Donates $100,000 to ASGE's Training Center

    The American Society for Gastrointestinal Endoscopy (ASGE) Foundation has received a donation of $100,000 from Mauna Kea Technologies to ASGE’s IT&T Capital Campaign, a fundraising project to construct a new facility that will provide cutting-edge technology and training to gastroenterology professionals. The donation will be made over five years.

    09/05/2012

    more

  • Cellvizio featured at Endocon 2012

    Cellvizio featured at Endocon 2012

    Cellvizio was featured in 5 live cases at Endocon 2012, the largest GI event in India. The ERCP case performed by A. Meining and J.H. Moon demonstrated the value of pCLE in characterizing a malignant stricture in real-time. Download the PDF

    03/05/2012


  • SCOPING OUT COLON CANCER

    SCOPING OUT COLON CANCER

    Live webcast on the benefits of using Cellvizio for smarter colonoscopies with Stanley B. Benjamin, MD, chief, and Firas H. Al-Kawas, MD, Division of Gastroenterology, and a testimonial from a patient whose life was saved after a colonoscopy.

    29/03/2012

    more

  • EndoNurse: New AMA Codes May Increase Access to Endoscopic Microscope

    EndoNurse: New AMA Codes May Increase Access to Endoscopic Microscope

    Mauna Kea Technologies announced that the American Medical Association's CPT (current procedural terminology) editorial panel has approved three Category I codes to cover use of Cellvizio in the gastrointestinal tract. Th

    15/03/2012

    more

  • MAUNA KEA TECHNOLOGIES’ CELLVIZIO® IS APPROVED FOR CATEGORY I CPT® CODES

    MAUNA KEA TECHNOLOGIES’ CELLVIZIO® IS APPROVED FOR CATEGORY I CPT® CODES

    Cellvizio® approved for Category I CPT Codes, facilitating reimbursement process in the United States. Download the PDF

    13/03/2012


  • Fewer Biopsies Go to Pathology Labs when Gastroenterologists Use New Miniature Microscope

    Fewer Biopsies Go to Pathology Labs when Gastroenterologists Use New Miniature Microscope

    Darkdaily.com: Advances in use of probe-based Confocal Laser Endomicroscopy (pCLE) could mean that GIs refer fewer specimens to clinical pathology laboratories.

    29/11/2011

    more

  • The Cellvizio App is Here

    The Cellvizio App is Here

    Discover state-of-the-art medical imaging technology via the Cellvizio App. Connect with the Cellvizio® community through the calendar, activate notifications to stay up to date on upcoming workshops and live shows, and browse the library of sample Cellvizio videos.

    28/11/2011

    more

  • 14/06/2012

    Cellvizio Live Show at IMAGE, Humanitas Hospital, Milan, Italy

    Cellvizio will be showcased at IMAGE: The 2nd International Live Endoscopy Course, June 14 - 16 at Humanitas Hospital, Milan, Italy.
  • 09/06/2012

    International Digestive Disease (IDD) Forum, Hong Kong

    This forum, organized by the Institute of Digestive Disease and the Chinese University of Hong-Kong offers cutting-edge advancements in the diagnosis and management of liver and gastrointestinal diseases, including but not limited to state-of-the-art lectures, clinical updates, live endoscopy demonstration, and challenging clinical cases.
    more
See all events
  • 03/05/2012

    Cellvizio GI Workshop in Irvine, CA, USA

    Acquire a basic understanding of how the Cellvizio system works, and learn how to interpret Cellvizio images of the esophagus, bile duct and colon. Live cases will be observed and the latest clinical data and case studies will be analyzed.
See all training opportunities
  • 11/04/2012

    Cellvizio News, April 2012

    We are gearing up for the 4th Annual International Conference of Cellvizio Users (ICCU) being held on April 13th-15th in Rome, Italy.
    more
See all newsletters
  • 16/05/2012

    MAUNA KEA TECHNOLOGIES RECEIVES 510(k) CLEARANCE FOR PORTFOLIO OF SMALLER DIAMETER CELLVIZIO® MINIPROBES

    Mauna Kea Technologies, leader in the endomicroscopy market and developer of Cellvizio®, the world’s smallest microscope, announced today that the U.S. Food and Drug Administration (FDA) has cleared a portfolio of smaller Cellvizio Miniprobes.
Read all our press releases

Contact us Français / English International Version | Go to the US Version